Stay updated with breaking news from Cingulate. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cingulate Inc. (NASDAQ:CING – Get Free Report) was the target of a large drop in short interest in the month of June. As of June 30th, there was short interest totalling 33,500 shares, a drop of 68.0% from the June 15th total of 104,800 shares. Based on an average daily trading volume, of 337,700 shares, […]
Cingulate Inc. (NASDAQ:CING – Get Free Report) saw a significant decrease in short interest in the month of June. As of June 30th, there was short interest totalling 33,500 shares, a decrease of 68.0% from the June 15th total of 104,800 shares. Approximately 0.4% of the shares of the company are sold short. Based on […]
08.06.2023 - Study Assessed Onset and Duration of CTx-1301 in Adults, Results Expected 3Q 2023 Pivotal Phase 3 Trials in Pediatric/Adolescent Patients on Schedule for 3Q 2023 Initiation KANSAS CITY, Kan., June 08, 2023 (GLOBE NEWSWIRE) - Cingulate Inc. ... Seite 1
Cingulate Inc. (NASDAQ:CING – Get Rating) was the recipient of a large decrease in short interest in the month of May. As of May 15th, there was short interest totalling 156,700 shares, a decrease of 45.5% from the April 30th total of 287,700 shares. Based on an average trading volume of 838,400 shares, the short-interest […]
KANSAS CITY, Kan., May 25, 2023 -- Cingulate Inc. , a biopharmaceutical company utilizing its proprietary Precision Timed Release™ drug delivery platform technology to build and advance a... | May 25, 2023